EPA to consider non-CFC inhaler market share "potential" in processing CFC exemption requests.

EPA TO CONSIDER "POTENTIAL" MARKET PENETRATION OF NON-CFC CONTAINING asthma products in processing requests for exemptions for chlorofluorocarbon-containing metered-dose inhalers, Environmental Protection Agency Essential Uses Program Manager Nina Bonnelycke told the International Conference on Ozone Protection Technologies in Washington, D.C. Oct. 23. EPA is "going to include consideration of [approved, CFC-free] alternatives and their potential for market penetration in its estimate" of companies' CFC needs that it provides to the United Nations Environment Program this year, Bonnelycke said.